JOHN MCCORMICK: Open Payments
NPI 1477066926 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,492 in 107 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,499 · 2025 $2,492
Food & beverage: $2,409Education: $83
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $449 |
| ABBVIE INC. | 20 | $413 |
| Janssen Biotech, Inc. | 22 | $405 |
| GENZYME CORPORATION | 13 | $359 |
| Lilly USA, LLC | 15 | $326 |
| LEO Pharma Inc. | 6 | $126 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $120 |
| UCB, Inc. | 6 | $106 |
| PFIZER INC. | 4 | $73 |
| Incyte Corporation | 2 | $51 |
Products named: TREMFYA, DUPIXENT, TALTZ, COSENTYX, SKYRIZI, RINVOQ, ILUMYA, Bimzelx.
Industry payments across AR — which companies pay providers there.
